Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: Assessment of early toxicity
| Autor: | Ajgal, Z., de Percin, S., Diéras, V., Pierga, J.Y., Campana, F., Fourquet, A., Kirova, Y.M. |
|---|---|
| Zdroj: | In Cancer / Radiothérapie April 2017 21(2):114-118 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect